Board of Directors gp_j5unjv
Board of Directors
Aaron B. Honigman
Mr. Honigman is the managing member of Laurel Biotech, which invests in the biopharmaceutical Industry, and is an investor and manager of the Honigman family enterprises. Mr. Honigman has over 20 years of experience in investment, real estate development and health care fields.
Mr. Furlong is CEO and a Director of the Dresner Foundation, which supports medical research and youth programs. Formerly a partner in a Michigan firm, Mr. Furlong is a certified public accountant and has over thirty years of experience working in real estate development and management fields.
Arthur H. Rubenstein, MBBCh
Dr. Rubenstein is an internationally-prominent endocrinologist recognized for clinical expertise and groundbreaking research in diabetes. Well-known for his inspired teaching, Dr. Rubenstein has served in numerous professional leadership positions during his career. These include President of the Association of Professors of Medicine; President of the Association of American Physicians; President of the Central Society for Clinical Research; Chairman of the American Board of Internal Medicine; Chairman of the Board of the Association of Academic Health Centers; and Chair of the National Diabetes Advisory Board.
Mr. Miller is the Managing Director and Global Life Science Practice Leader for Diversified Search, a leading Retained Executive Search Firm. Mr. Miller has a 20-year history of identifying leadership for global life sciences companies from the board level to general management positions of impact.
Patrick M. O’Keefe, CPA/ABV/CFF, CTP, MAFF
Patrick O’Keefe has been responsible for the raising of debt and equity capital and is currently the CEO of Grow Michigan, a mezzanine fund supported by the Michigan Strategic Fund and nineteen financial institutions.